SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001566044-17-000018
Filing Date
2017-12-05
Accepted
2017-12-04 17:31:35
Documents
8

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 3354432
2 filename2.htm EX-10.2 453523
3 chronicitchcough.jpg GRAPHIC 703289
4 cumulativedistributionfuncti.jpg GRAPHIC 37192
5 image001a05.jpg GRAPHIC 169709
6 menlologo.jpg GRAPHIC 125687
7 tcp101vaschangefrombaselinen.jpg GRAPHIC 110258
8 updatedpipelineimagev2.jpg GRAPHIC 54514
  Complete submission text file 0001566044-17-000018.txt   5443087
Mailing Address 4085 CAMPBELL AVENUE, SUITE 200 MENLO PARK CA 94025
Business Address 4085 CAMPBELL AVENUE, SUITE 200 MENLO PARK CA 94025 650-486-1416
Menlo Therapeutics, Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01766 | Film No.: 171238030
SIC: 2834 Pharmaceutical Preparations